Mumbai, October 23 (Udaipur Kiran) — Shares of Aurobindo Pharma edged higher in Thursday’s session after the company announced the incorporation of a new wholly owned subsidiary in Chile, marking its latest step toward expanding operations in South America.
The stock was trading at ₹1,111.90, up by ₹10.90 or 0.99%, compared to its previous close of ₹1,101.00 on the BSE. It opened at ₹1,112.00 and hit an intraday high of ₹1,120.00 and a low of ₹1,104.40. Around 12,509 shares were traded on the counter.
Aurobindo Pharma’s market capitalisation stands at ₹64,596.76 crore. The stock has a 52-week high of ₹1,482.25 (October 22, 2024) and a 52-week low of ₹994.35 (April 7, 2025). Over the past week, it traded between ₹1,120.00 and ₹1,093.00.
Promoters currently hold 51.82%, while institutional and non-institutional investors hold 41.81% and 6.38%, respectively.
The company said its wholly owned subsidiary Helix Healthcare B.V. has incorporated a new subsidiary in Chile under the name Aurobindo Pharma Chile SpA. The objective is to expand the company’s pharmaceutical products business in the South American market.
In addition, its wholly owned step-down subsidiary, Eugia Pharma B.V., has also incorporated a new entity named Eugia Pharma Chile SpA, further strengthening the group’s presence in the region.
This strategic move aligns with Aurobindo Pharma’s global expansion roadmap and is expected to enhance its export potential and market penetration in Latin America’s growing pharmaceutical sector.
Aurobindo Pharma is engaged in the manufacturing and marketing of active pharmaceutical ingredients (APIs), intermediates, and generic formulations across multiple therapeutic areas, including anti-infectives, antibiotics (oral and sterile), pain management, and osteoporosis treatments.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
